Dabur Pharmaceutical Ltd
Pharmaceutical company trading medical goods, incorporated in 1985 with registered office in New Delhi.
1985 | Delhi (India) | Active
Dabur Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 1.59 M
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 3.60%
- Ebitda 31.71%
- Net Worth -11.03%
- Total Assets -7.64%
About Dabur Pharmaceutical
Dabur Pharmaceutical Ltd (DPL) is a Public Limited Indian Non-Government Company incorporated in India on 25 June 1985 and has a history of 39 years and eight months. Its registered office is in Delhi, India.
The Corporate was formerly known as Key Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 1.59 M, as per Ministry of Corporate Affairs (MCA) records.
Anurag Gupta, Pankaj Bhardwaj, and Akhil Mahajan serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL1985PLC021308
- Company No.
021308
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Jun 1985
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Dabur Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Gupta  | Director | 27-Mar-2015 | Current |
| Pankaj Bhardwaj | Director | 25-Jul-2019 | Current |
| Akhil Mahajan | Director | 01-Feb-2024 | Current |
Financial Performance of Dabur Pharmaceutical.
Dabur Pharmaceutical Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dabur Pharmaceutical?
In 2023, Dabur Pharmaceutical had a promoter holding of 97.11% and a public holding of 2.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Param Investments Private LimitedPankaj Bhardwaj and Akhil Mahajan are mutual person
Althea Drf Lifesciences LimitedAnurag Gupta is a mutual person
Adfluence Hub Private LimitedPankaj Bhardwaj is a mutual person
_LIMITED.webp)
British Health Products (India) LimitedPankaj Bhardwaj is a mutual person
Dabur Ayurvedic Specialities LimitedPankaj Bhardwaj and Akhil Mahajan are mutual person
- Capcorp Advisors Llp
Pankaj Bhardwaj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dabur Pharmaceutical?
Unlock and access historical data on people associated with Dabur Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dabur Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dabur Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Dabur Pharmaceutical
Recent activity within the organization
- Director Appointment
Akhil Mahajan was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 1 year 1 month .
- Annual General Meeting
Dabur Pharmaceutical Ltd last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
- Balance Sheet
Dabur Pharmaceutical Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Director Appointment
Pankaj Bhardwaj was appointed as a Director was appointed as a Director on 25 Jul 2019 & has been associated with this company since 5 years 7 months .
- Director Appointment
Anurag Gupta was appointed as a Director was appointed as a Director on 27 Mar 2015 & has been associated with this company since 9 years 11 months .
- Company Incorporation
Dabur Pharmaceutical Ltd was registered on 25 Jun 1985 with Roc Delhi & aged 39 years 8 months as per MCA records.
Recent News, Updates & Announcement
Dabur India introduces an all-women production team at plant near Indore.Dabur India has established an all-women production line at its largest greenfield plant near Indore, with 20 women currently engaged in producing Vatika hair oils. This initiative aims to promote women's empowerment in manufacturing and build a more diverse workforce. Dabur plans to expand the initiative by adding 30 more women to its factory workforce. .
- Dabur to invest Rs 135 crore, set up new plant in South India.
The move is aimed at strengthening its supply chain in the region.
- Dabur Q3 update: Revenue to see mid-to-high single digit growth; co sees improvement in demand trends.
With pricing growth remaining subdued due to price increases in the base year, the growth during the third quarter is largely volume-led. Early signs of revival in consumption are visible with improving trends in volumes, the company said in a filing..
- Mid-to-high single-digit revenue growth expected in Q3, says Dabur in Q3 update.
The maker of Real juice, Hommade condiments and chyawanprash noted in a filing to the stock exchanges that its foods and beverages segment would lead growth in the quarter, usually the best performer in the October-December quarter due to the festive season and its juices portfolio. Dabur said the third quarter has been better than expectations, also driven by its acquired Badshah masala franchise and its international business..
Frequently asked questions
What is the Incorporation or founding date of Dabur Pharmaceutical Ltd?
Dabur Pharmaceutical Ltd was incorporated on 25 Jun 1985.
What is authorized share capital and paid-up capital of Dabur Pharmaceutical Ltd?
The authorized share capital of Dabur Pharmaceutical Ltd is ₹ 2.10 Cr and paid-up capital is ₹ 1.59 M.
Who are the current board members & directors of Dabur Pharmaceutical Ltd?
Currently 3 directors are associated with Dabur Pharmaceutical Ltd.
- Anurag Gupta
- Pankaj Bhardwaj
- Akhil Mahajan
What is the registered address of Dabur Pharmaceutical Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Dabur Pharmaceutical Ltd is 1St Floor, Ashi 19 Rouse Avenue Institutional Area India, New Delhi, 110002.
What is the corporate identification number (CIN) and company number of Dabur Pharmaceutical Ltd?
The corporate identification number (CIN) of Dabur Pharmaceutical Ltd is U24231DL1985PLC021308 and the company number is 021308 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Dabur Pharmaceutical Ltd, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Dabur Pharmaceutical Ltd has experienced an downturn of -11.03%.
When was the last Balance Sheet of Dabur Pharmaceutical Ltd filed with the ROC?
The most recent Balance Sheet for Dabur Pharmaceutical Ltd was filed with the ROC on 31 Mar 2023.
People also Viewed
Mohit BurmanDirector
Aditya BurmanDirectorAB
Anand BurmanDirectorRB
Ramesh BurmanDirectorST
Shailendra TandonDirectorAK
Anil KumarDirectorRM
Rakesh MalhotraDirector
Similar Companies Based on Pharmaceutical Retailers & Distributors
Wellness Forever Medicare Limited Mumbai, Maharashtra, India
Sun Pharma Distributors Limited Mumbai, Maharashtra, India
Novartis Healthcare Private Limited Mumbai, Maharashtra, India
Mylan Pharmaceuticals Private Limited Hyderabad, Telangana, India
Msd Pharmaceuticals Private Limited New Delhi, Delhi, India
Aster Dm Healthcare Limited Bangalore, Karnataka, India
Reckitt Benckiser Healthcare India Private Limited Gurugram, Haryana, India
Trident Chemphar Limited Hyderabad, Telangana, India